MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
13.77
+0.63 (4.79%)
Sep 4, 2026, 4:00 PM EDT - Market closed
MapLight Therapeutics Market Cap
MapLight Therapeutics has a market cap or net worth of $765.28 million as of September 4, 2026.
Market Cap
765.28M
Enterprise Value
462.54M
1-Year Change
n/a
Ranking
Category
Stock Price
$13.77
ChartMarket Cap Chart
Since the IPO on October 27, 2025, MapLight Therapeutics's market cap has increased from $704.29M to $765.28M, an increase of 8.66%. That is a compound annual growth rate of 10.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 765.28M | -0.17% |
| Dec 31, 2025 | 766.56M | 8.84% |
| Oct 27, 2025 | 704.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharming Group | 797.03M |
| DBV Technologies | 793.00M |
| Monopar Therapeutics | 789.08M |
| Aura Biosciences | 784.01M |
| AgomAb Therapeutics NV | 777.13M |
| Neurogene | 772.44M |
| Phathom Pharmaceuticals | 754.59M |
| Oculis Holding AG | 751.28M |